Journal
VACCINE
Volume 41, Issue 7, Pages 1286-1289Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2023.01.021
Keywords
Measles; Elimination; Vaccination; COVID-19; Italy; Europe
Categories
Ask authors/readers for more resources
From January 2020 to July 2022, there were 120 reported measles cases in Italy with a sharp decline compared to the pre-COVID-19 period, possibly due to non-pharmaceutical interventions. Among the cases, 103 were infected before the national lockdown in March 2020. A quarter of cases reported complications. With the easing of pandemic measures, countries need to ensure high vaccination coverage and close immunity gaps to avoid future outbreaks.
From January 2020 to July 2022, 120 measles cases were reported to the Italian national surveillance system, of which 105 had symptom onset in 2020, nine in 2021 and six in the first seven months of 2022. This represents a sharp decline compared to the time period immediately preceding the COVID-19 pandemic, most likely due to the non-pharmaceutical interventions implemented to prevent SARS-CoV2 transmission. Of 105 cases reported in 2020, 103 acquired the infection before a national lockdown was instituted on 9 March 2020. Overall, one quarter of cases reported at least one complication. As non-pharmaceutical pandemic measures are being eased worldwide, and considering measles seasonality, infectiousness, and its potential severity, it is important that countries ensure high vaccination coverage and close immunity gaps, to avoid risk of future outbreaks.(c) 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND license (http://creativecommons.orgilicenses/by-nc-nd/4.0/).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available